Leidos (NYSE:LDOS) Issues Quarterly Earnings Results

Leidos (NYSE:LDOS) posted its earnings results on Tuesday. The aerospace company reported $2.37 EPS for the quarter, topping the consensus estimate of $2.24 by $0.13, Zacks reports. Leidos had a net margin of 7.37% and a return on equity of 30.31%. Leidos updated its FY 2025 guidance to 10.350-10.750 EPS.

Leidos Stock Performance

Shares of LDOS stock opened at $137.37 on Wednesday. The company has a 50 day moving average price of $148.78 and a 200-day moving average price of $157.63. Leidos has a 52 week low of $113.67 and a 52 week high of $202.90. The firm has a market capitalization of $18.33 billion, a PE ratio of 15.65, a P/E/G ratio of 0.92 and a beta of 0.66. The company has a quick ratio of 1.15, a current ratio of 1.23 and a debt-to-equity ratio of 0.87.

Leidos Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, March 28th. Stockholders of record on Friday, March 14th will be paid a $0.40 dividend. The ex-dividend date is Friday, March 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.16%. Leidos’s dividend payout ratio is presently 18.22%.

Insider Transactions at Leidos

In other Leidos news, Director Noel B. Geer acquired 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 20th. The shares were bought at an average price of $161.13 per share, with a total value of $322,260.00. Following the completion of the acquisition, the director now owns 2,000 shares in the company, valued at $322,260. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.96% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on LDOS. The Goldman Sachs Group cut shares of Leidos from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $228.00 to $153.00 in a research report on Thursday, December 12th. Royal Bank of Canada raised their target price on shares of Leidos from $145.00 to $180.00 and gave the stock a “sector perform” rating in a research report on Wednesday, October 30th. Truist Financial dropped their target price on shares of Leidos from $205.00 to $185.00 and set a “buy” rating for the company in a research report on Friday, November 22nd. Cantor Fitzgerald started coverage on shares of Leidos in a research note on Friday, February 7th. They issued an “overweight” rating and a $185.00 price target for the company. Finally, Barclays increased their price target on shares of Leidos from $165.00 to $210.00 and gave the stock an “overweight” rating in a research note on Monday, November 4th. Five equities research analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $179.33.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.